SMART-CHOICE HF Subpopulation Algorithm

Clinical calculation support · Verify results before clinical use

Patient assessment

Enter LVEF to classify the ejection-fraction phenotype. Other clinical fields are optional context and do not generate a mortality score.

LVEF CLASSIFICATION
Accepts values from 0 to 100%. Confirm the measurement and clinical context.
Reset form

About LVEF-based HF classification

This tool classifies the LVEF range only. A measured LVEF by itself does not establish a diagnosis of heart failure in every patient. For HFmrEF and HFpEF, guidelines emphasize evidence supporting increased left ventricular filling pressures in the appropriate clinical setting.

Phenotype thresholds

PhenotypeLVEFClinical note
HFrEF≤40%Reduced EF; evaluate symptoms, causes, and guideline-directed management.
HFmrEF41–49%For HF diagnosis, assess evidence of increased filling pressures.
HFpEF≥50%For HF diagnosis, assess objective evidence of increased filling pressures or relevant structural/functional abnormalities.
HFimpEFPrior ≤40%, follow-up >40%Requires a documented previous LVEF; this single-measurement form cannot determine HFimpEF.

What this tool does not calculate

It does not calculate MAGGIC or GWTG-HF mortality risk. MAGGIC uses a specific 13-variable model, while GWTG-HF uses its own validated admission variables and scoring method. A custom point total or risk band must not be substituted for either model.

References

Heidenreich PA, Bozkurt B, Aguilar D, et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022;79(17):e263–e421. Guideline DOI
Pocock SJ, Ariti CA, McMurray JJV, et al.Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. European Heart Journal. 2013;34(19):1404–1413. PubMed PMID: 23095984
Peterson PN, Rumsfeld JS, Liang L, et al.A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With The Guidelines program. Circ Cardiovasc Qual Outcomes. 2010;3(1):25–32. DOI: 10.1161/CIRCOUTCOMES.109.854877
Clinical disclaimer: This educational tool provides an LVEF-based phenotype classification, not a complete HF diagnostic assessment, individualized prognosis, or treatment recommendation. Consider the clinical presentation, prior LVEF, imaging quality, natriuretic peptides, filling pressures, comorbidities, and current local/international guidelines. Do not use this output as the sole basis for clinical decisions.